Rheumatic fever is a systemic inflammatory disease caused by an immune and inflammatory response to infection by group A beta-hemolytic streptococci in individuals with a genetic predisposition. In its acute form, rheumatic fever is a febrile illness that occurs about 2 to 3 weeks after infection and is characterized by inflammation of the joints, skin, nervous system, and heart. If left untreated, rheumatic fever can lead to scarring and structural deformities of the heart resulting in rheumatic heart disease (RHD). This literature review aimed to describe acute rheumatic fever and rheumatic heart disease in children. Therapy for acute rheumatic fever is aimed at eradicating streptococcal infection regimen 10 days of antibiotics NSAIDs are used as agent anti-inflammatory for rheumatic carditis and arthritis and help relieve symptoms, but does not prevent complications. Serious carditis may require diuretics and vasodilators, and recovery may take up to 12 months. Damaged valve repair surgery may be necessary in cases of recurrent chronic rheumatic fever or carditis. In conclusion, rheumatic fever is a systemic inflammatory disease caused by an immune and inflammatory response to infection by group A beta-hemolytic streptococci in individuals with a genetic predisposition. If left untreated, rheumatic fever can lead to scarring and structural deformities of the heart resulting in rheumatic heart disease (RHD).
Background The prevalence of stunting in Indonesia is high, with particularly negative impacts on health during childhood as well as adolescence. Stunting impacts the health of children as well as adults, especially with regards to future obesity. Therefore, evaluating body composition of stunted children before 2 years of age is necessary. Objective To compare upper arm fat and muscle measurements in stunted and non-stunted children aged 0-24 months of age. Methods We analyzed secondary data of the Division of Nutrition and Metabolic Disease, Department of Child Health, Universitas Gadjah Mada Medical School, Yogyakarta which were collected using cluster random sampling from the Yogyakarta Special Province. We compared upper arm fat area (UFA), including the upper arm fat area estimate (UFE) and the upper arm fat percentage (UFP), as well as upper arm muscle area (UMA) and upper arm muscle area estimate (UME), among stunted and non-stunted children aged 0-24 months. Results We analyzed 2,195 children. The prevalence of stunting was 354/2,195 (16.1%). The UFA, UFE, and UFP among stunted children were significantly lower compared to non-stunted children aged 7-12 months [UFA: 4.48 vs. 5.05 cm2 (P <0.001), respectively; UFE: 4.88 vs. 5.55 cm2 (P <0.001), respectively; and UFP: 30.82 vs. 32.58% (P = 0.03), respectively]. The UMA in children aged 7-12 months was also significantly lower in stunted than in non-stunted children [11.31 vs. 11.79 cm2 (P = 0.02), respectively], as well as in children aged 13-24 months [11.05 vs. 11.75 cm2 (P <0.001), respectively]. In addition, the UME in children aged 13-24 months was significantly lower in stunted compared to non-stunted children [10.50 vs. 11.18 cm2 (P <0.001), respectively]. Conclusion The UFA in children aged 7-12 months is smaller in stunted than in non-stunted children, whereas UMA in children aged 7-12 months and 13-24 months was smaller in stunted compared to non-stunted children. [Paediatr Indones. 2017;57:252-61; doi: http://dx
Background The prevalence of stunting in Indonesia is high, with particularly negative impacts on health during childhood as well as adolescence. Stunting impacts the health of children as well as adults, especially with regards to future obesity. Therefore, evaluating body composition of stunted children before 2 years of age is necessary. Objective To compare upper arm fat and muscle measurements in stunted and non-stunted children aged 0-24 months of age. Methods We analyzed secondary data of the Division of Nutrition and Metabolic Disease, Department of Child Health, Universitas Gadjah Mada Medical School, Yogyakarta which were collected using cluster random sampling from the Yogyakarta Special Province. We compared upper arm fat area (UFA), including the upper arm fat area estimate (UFE) and the upper arm fat percentage (UFP), as well as upper arm muscle area (UMA) and upper arm muscle area estimate (UME), among stunted and non-stunted children aged 0-24 months. Results We analyzed 2,195 children. The prevalence of stunting was 354/2,195 (16.1%). The UFA, UFE, and UFP among stunted children were significantly lower compared to non-stunted children aged 7-12 months [UFA: 4.48 vs. 5.05 cm2 (P <0.001), respectively; UFE: 4.88 vs. 5.55 cm2 (P <0.001), respectively; and UFP: 30.82 vs. 32.58% (P = 0.03), respectively]. The UMA in children aged 7-12 months was also significantly lower in stunted than in non-stunted children [11.31 vs. 11.79 cm2 (P = 0.02), respectively], as well as in children aged 13-24 months [11.05 vs. 11.75 cm2 (P <0.001), respectively]. In addition, the UME in children aged 13-24 months was significantly lower in stunted compared to non-stunted children [10.50 vs. 11.18 cm2 (P <0.001), respectively]. Conclusion The UFA in children aged 7-12 months is smaller in stunted than in non-stunted children, whereas UMA in children aged 7-12 months and 13-24 months was smaller in stunted compared to non-stunted children. [Paediatr Indones. 2017;57:252-61; doi: http://dx
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.